Hormonal therapies, pregnancy, and PCOS can increase clotting and vascular risks in some women. This report assesses genetic predisposition to impaired blood flow, clot formation, and vascular inflammation—supporting safer fertility planning, pregnancy management, and hormone-based interventions.